|
|
||||||||
ORIGINAL RESEARCH |
From the Department of Obstetrics and Gynecology, New York University, New York, New York; University of Colorado Health Sciences Center and Denver Health Medical Center, Denver, Colorado; Boston University, Boston, Massachusetts; University of Washington, Seattle Washington; Evanston Hospital, Evanston, Illinois; Northwestern University, Chicago, Illinois; University of Michigan, Ann Arbor, Michigan; Columbia University, New York, New York; Mount Sinai Medical Center, New York, New York; University Southern California, Los Angeles, California; KapiOlani Medical Center, Honolulu, Hawaii; Loyola University, Maywood, Illinois.
Address reprint requests to: Men-Jean Lee, MD, NYU Medical Center, Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, 550 First Avenue, Room 9E2, New York, NY, 10016; e-mail: mjl5{at}nyu.edu.
OBJECTIVE: This study was performed to evaluate the efficacy of weekly courses of antenatal corticosteroids compared with a single course in women with preterm premature rupture of membranes (PROM).
METHODS: A planned secondary analysis of women with preterm PROM who participated in a multicenter, randomized trial of weekly courses of antenatal corticosteroids versus single-course therapy was performed. After their first course of standard antenatal steroid therapy, administered between 24 to 326/7 weeks of gestation, consenting women were randomly assigned to receive betamethasone versus placebo injections weekly until 340/7 weeks of gestation. Maternal and neonatal morbidities were compared between the 2 groups.
RESULTS: Of the 161 women with preterm PROM, 81 women were assigned to receive weekly courses of steroids and 80 to the single-course group. There were no significant differences in composite morbidity between the groups (27 [34.2%] of 81 patients versus 33 [41.8%] of 80 patients, P = .41). Chorioamnionitis was higher in patients who received weekly courses of antenatal steroids (39 [49.4%] of 81 patients versus 25 [31.7%] of 80 patients, P = .04).
CONCLUSION: Weekly courses of antenatal steroids in women with preterm PROM did not improve neonatal outcomes beyond that achieved with single-course therapy and was associated with an increased risk of chorioamnionitis. Antenatal steroid therapy should not be routinely repeated in patients with preterm PROM.
LEVEL OF EVIDENCE: I
This article has been cited by other articles:
![]() |
V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus Endocr. Rev., April 1, 2006; 27(2): 141 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
Other articles noted Evid. Based Med., September 1, 2004; 9(5): e5 - e5. [Full Text] [PDF] |
||||
![]() |
Use a single course of steroids for preterm rupture of membranes BMJ, May 1, 2004; 328(7447): . [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |